Assessing perfusion changes during whole brain irradiation for patients with cerebral metastases.
OBJECTIVE
To assess perfusion changes within brain and correlate these with clinical symptoms during whole brain radiotherapy (WBRT) for cerebral metastases.


METHODS
Fourteen patients with cerebral metastases underwent dynamic CT perfusion scans during palliative whole brain irradiation. Perfusion scans were performed on Day 1 prior to initial radiotherapy treatment, then on Day 2, and on Day 5 immediately after completion of radiotherapy. Measurements of cerebral blood flow (CBF), cerebral blood volume (CBV), mean transit time (MTT) and capillary surface area permeability product (PS) were performed for each perfusion scan, and daily symptom assessment was taken prior to initial perfusion scan and thereafter prior to each daily radiation treatment.


RESULTS
Utilizing Day 1 as baseline, a 19% increase (P = 0.033) was noted in PS at Day 2, (median 1.47 ml/100 g/min), which returned to Day 1 range at Day 5 (median 1.31 ml/100 g/min). When symptoms were correlated with perfusion parameters, a statistically significant association between change in MTT with change in headache scores was observed, baseline to Day 2 (P = 0.019), and a trend between change in nausea scores with change in CBV (P = 0.059) as well as change in MTT (P = 0.098), baseline to Day 5.


CONCLUSIONS
This study has demonstrated the feasibility of a non-invasive technique to assess changes occurring within the human brain during a course of radiation treatment. Dynamic perfusion tomography provides insight into the pathophysiological processes taking place and allows correlation with patient symptomatology.
Millar
Barbara-Ann M
BA
Department of Radiation Oncology, Princess Margaret Hospital, Toronto, Ontario, Canada. barbara-ann.millar@rmp.uhn.on.ca
Purdie
Thomas G
TG
Yeung
Ivan
I
Pond
Gregory R
GR
Billingsley
Susan
S
Wong
Rebecca
R
Haddad
Peiman
P
Wong
C Shun
CS
Laperriere
Normand
N
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001921:Brain / Q000098:blood supply* / Q000528:radiation effects*; D001932:Brain Neoplasms / Q000098:blood supply / Q000532:radiotherapy* / Q000556:secondary*; D002560:Cerebrovascular Circulation / Q000528:radiation effects*; D016371:Cranial Irradiation; D019583:Dose Fractionation, Radiation; D004307:Dose-Response Relationship, Radiation; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010865:Pilot Projects; D012039:Regional Blood Flow / Q000528:radiation effects; D018709:Statistics, Nonparametric; D014057:Tomography, X-Ray Computed
AJNR Am J Neuroradiol. 2002 May;23 (5):828-32
12006286
Radiology. 2002 Jan;222(1):227-36
11756730
Acta Neurochir (Wien). 1995;136(1-2):82-6; discussion 86-7
8748832
Neuroradiology. 2003 Jun;45(6):373-6
12719953
Eur J Cancer. 2002 Mar;38(4):487-96
11872340
Int J Radiat Oncol Biol Phys. 2000 Aug 1;48(1):53-8
10924971
AJNR Am J Neuroradiol. 2001 May;22(5):905-14
11337336
Brain Res. 2003 Apr 18;969(1-2):59-69
12676365
Phys Med Biol. 2001 Dec;46(12):3161-75
11768498
Eur Radiol. 2001;11(7):1220-30
11471616
Radiother Oncol. 1995 Feb;34(2):132-6
7597211
J Comput Assist Tomogr. 2004 Jan-Feb;28(1):55-62
14716233
Cancer Res. 2003 Sep 15;63(18):5950-6
14522921
AJNR Am J Neuroradiol. 2000 Mar;21(3):462-70
10730636
Melanoma Res. 1999 Dec;9(6):611-3
10661774
Radiology. 1999 Oct;213(1):141-9
10540654